Rasmussen Theodore P相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Mechanisms of Action of the US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs

美国食品药品监督管理局批准的反义寡核苷酸药物的作用机制

期刊:BioDrugs

影响因子:6.9

doi:10.1007/s40259-024-00665-2

Sang, Angela; Zhuo, Selena; Bochanis, Adara; Manautou, José E; Bahal, Raman; Zhong, Xiao-Bo; Rasmussen, Theodore P

发表日期：2024

文献求助收藏

Correlations of Long Noncoding RNA HNF4A-AS1 Alternative Transcripts with Liver Diseases and Drug Metabolism.

长链非编码RNA HNF4A-AS1替代转录本与肝脏疾病和药物代谢的相关性

期刊:Drug Metabolism and Disposition

doi:10.1124/dmd.124.001873

Jin Jing, Nguyen Le Tra Giang, Wassef Andrew, Sadek Ragui, Schmitt Timothy M, Guo Grace L, Rasmussen Theodore P, Zhong Xiao-Bo

发表日期：2024

文献求助收藏

Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver Origin

利用核酸疗法靶向肝脏治疗肝源性系统性疾病

期刊:Pharmacological Reviews

影响因子:17.3

doi:10.1124/pharmrev.123.000815

Gogate, Anagha; Belcourt, Jordyn; Shah, Milan; Wang, Alicia Zongxun; Frankel, Alexis; Kolmel, Holly; Chalon, Matthew; Stephen, Prajith; Kolli, Aarush; Tawfik, Sherouk M; Jin, Jing; Bahal, Raman; Rasmussen, Theodore P; Manautou, José E; Zhong, Xiao-Bo

发表日期：2023

文献求助收藏

Absorption, Distribution, Metabolism, and Excretion of US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs

美国食品药品监督管理局批准的反义寡核苷酸药物的吸收、分布、代谢和排泄

期刊:Drug Metabolism and Disposition

doi:10.1124/dmd.121.000417

Migliorati, Julia M; Liu, Sunna; Liu, Anna; Gogate, Anagha; Nair, Sreenidhi; Bahal, Raman; Rasmussen, Theodore P; Manautou, José E; Zhong, Xiao-Bo

发表日期：2022

文献求助收藏

Adverse Drug Reactions and Toxicity of the Food and Drug Administration-Approved Antisense Oligonucleotide Drugs

美国食品药品监督管理局批准的反义寡核苷酸药物的不良反应和毒性

期刊:Drug Metabolism and Disposition

doi:10.1124/dmd.121.000418

Alhamadani, Feryal; Zhang, Kristy; Parikh, Rajvi; Wu, Hangyu; Rasmussen, Theodore P; Bahal, Raman; Zhong, Xiao-Bo; Manautou, José E

发表日期：2022

文献求助收藏

Nephrotoxicity of marketed antisense oligonucleotide drugs

已上市反义寡核苷酸药物的肾毒性

doi:10.1016/j.cotox.2022.100373

Wu, Hangyu; Wahane, Aniket; Alhamadani, Feryal; Zhang, Kristy; Parikh, Rajvi; Lee, SooWan; McCabe, Evan M; Rasmussen, Theodore P; Bahal, Raman; Zhong, Xiao-Bo; Manautou, José E

发表日期：2022

文献求助收藏

The growth of siRNA-based therapeutics: Updated clinical studies

基于siRNA的疗法的发展：最新临床研究

期刊:Biochemical Pharmacology

影响因子:5.6

doi:10.1016/j.bcp.2021.114432

Zhang, M May; Bahal, Raman; Rasmussen, Theodore P; Manautou, José E; Zhong, Xiao-Bo

发表日期：2021

文献求助收藏

Emerging Therapeutic Modalities against COVID-19

针对新冠肺炎的新兴治疗方法

期刊:Pharmaceuticals

影响因子:4.8

doi:10.3390/ph13080188

Malik, Shipra; Gupta, Anisha; Zhong, Xiaobo; Rasmussen, Theodore P; Manautou, Jose E; Bahal, Raman

发表日期：2020

文献求助收藏

Development of precision medicine approaches based on inter-individual variability of BCRP/ABCG2

基于BCRP/ABCG2个体间差异的精准医疗方法开发

期刊:Acta Pharmaceutica Sinica B

影响因子:14.6

doi:10.1016/j.apsb.2019.01.007

Chen, Liming; Manautou, Jose E; Rasmussen, Theodore P; Zhong, Xiao-Bo

发表日期：2019

文献求助收藏

Genetic Variations Associated with Anti-Tuberculosis Drug-Induced Liver Injury

与抗结核药物引起的肝损伤相关的基因变异

doi:10.1007/s40495-018-0131-8

Bao, Yifan; Ma, Xiaochao; Rasmussen, Theodore P; Zhong, Xiao-Bo

发表日期：2018

文献求助收藏